Home  >  Products  >  BCAR1 (breast cancer anti-estrogen resistance 1 ) Blocking Peptide (the C terminal of BCAR1)(100ug)
BCAR1 (breast cancer anti-estrogen resistance 1 ) Blocking Peptide (the C terminal of BCAR1)(100ug)

BCAR1 (breast cancer anti-estrogen resistance 1 ) Blocking Peptide (the C terminal of BCAR1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-BCAR1 Antibody (ARP63355_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63355
Size: 100ug
Weight: 72kDa
Gene: 9564
Format: Lyophilized powder
Target: BCAR1, or CAS, is an Src family kinase substrate involved in various cellular events, including migration, survival, transformation, and invasion.
Alternative names: CAS; CAS1; CASS1; CRKAS; FLJ12176; FLJ45059; P130Cas
See Full Product Listings >